Looking at what MXC is doing at the moment - product lines that are essentially in the herbal medicine category - it is difficult to see what the investment would be.
They were a cannabis company that was to produce and distribute that product. It has morphed into something completely different. In its new form, it just does not have sufficient bulk and the limited focus of its products to really have much impact anymore.
Add to the pot the incredible debt levels compares to the miniscule revenue stream and one would have to consider future solvency at this stage. Some of the products could be picked up by a larger player in the field but well below the $26mil company valuation. Maybe worth to that big player a couple of million only.
Ann: Change of External Financial Auditor, page-21
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.5¢ | 24.0¢ | $137.1K | 549.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2200 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |